I-YK-11 SARMs Izongezo zokwakha uMzimba kuBantu abaDala abaKhawuleza ukufumana izihlunu zeCas 431579-34-9
Iinkcukacha eziKhawulezayo
Igama lemveliso | YK11 |
Isithethantonye | (17-alpha,20E)17,20-[(1-methoxyethylidene)bis(oxy)] 3-oxo-19-norpregna-4,20-diene 21-carboxylic acid methyl ester |
CASE | 431579-34-9 |
Isivavanyi | 99% |
Imbonakalo | Umgubo omhlophe wekristale |
Ukupakisha | 1kg umnatha/ibhegi yefoil, 5kg/igubu. |
Umgangatho | Umgangatho woShishino |
Ugcino | Ukufaka umbala, ukuGcinwa kokuGcinwa |
Ukusetyenziswa | Ukulahleka kwamafutha;ukukhula kwezihlunu |
IFomu yeMolekyuli | C152H252N44O42 |
Ubunzima beMolekyuli | 3,367.2 |
Izibonelelo ze-YK-11
1. Ubungakanani obubhityileyo buzuza ngaphandle kokugcinwa kwamanzi
2. Ukwandisa ubungakanani bemisipha kunye namandla
3. Ukuqina kwezihlunu
4. Ukunyuka kumanqanaba eFollistatin
5. Ukuvinjelwa kwamanqanaba e-Myostatin
6. Ukuvumela ukuba ugqithe kakhulu kwimfuzo yomzimba wakho malunga nokwanda kobunzima bezihlunu.
7. Ivelisa izihlunu ngendlela eyahluke ngokupheleleyo kuneeSARM, Steroids, okanye HGH, ngoko inokongezwa ngokwethiyori kuwo nawuphi na umjikelo wokukhula kwemisipha eyongezelelweyo kunye ne-synergy.
8. Ukunyuswa kwe-muscular fullness kunye neepompo ezingcono
YK-11 Umthamo
Ukuthatha i-dose e-Moderate (4mg - 8mg ngosuku, i-2 kwii-capsules ze-4 ngosuku) ye-"YK-11" umsebenzisi unokulindela ukufumana i-Aesthetic Physique (i-Lean, Hard and Strong).
Ukuthatha i-dose enkulu (i-18mg - 22mg ngosuku, i-9 kwii-capsules ze-11) ze "YK-11" umsebenzisi uya kufumana ukufumana i-Muscle Tissue engaphezulu kunye nokugcina i-Extreme Muscle Fullness (I-"Pumped" Look) 24/7.
Oku kubangelwa izakhono ze "YK-11" ezibangela ukuba iiseli ze-muscle zivelise i-Follistatin eninzi (nangaphezulu kwe-DHT Steroids), enceda ukuvimbela ukuveliswa kweMyostatin (iMyostatin - imida yokukhula kwemisipha).Le SARM inamandla okuba ilungile njengeTestosterone kwixesha lokuQiniswa kwemisipha, kodwa ngaphandle kwemiphumo emibi.
Uphando lokuqala ngumphandi waseJapan, uYuichiro Kanno, kwi-2011 kwiYunivesithi yaseToho, uye wabonisa ukuba "i-YK-11" inamathele kwi-androgen receptor kwaye yenza iiseli ze-muscle zivelise izinto ezininzi ze-anabolic.Kwakhona wafumanisa ukuba "i-YK-11" ibangela ukuba iiseli ze-muscle zivelise i-Follistatin eninzi, eyanciphisa i-Myostatin kwaye ikhulise ukukhula kwemisipha.
YK-11 COA
IGAMA LEMVELISO | YK11 | ||
Inombolo yeCAS. | 1370003-76-1 | Ubungakanani | 18.5kg |
Ugcino | Kwisitya esingangeni moya, sikhuselwe ekukhanyeni. | ||
Izinto zokuhlalutya | Inkcazo | Iziphumo | |
Inkcazo | Umgubo omhlophe ukuya kumhlophe | Iyahambelana | |
1HNMR | Ihambelana nesakhiwo | Iyahambelana | |
Intsalela ekutshisweni | ≤0.5% | 0.08 | |
Ilahleko ekomisweni | ≤2.0% | 0.72 | |
Isivavanyi | ≥99.0% | 99.62 |
Iimveliso ezinxulumeneyo
Igama | HAYI. | Ukusetyenziswa |
RAD140 | 1182367-47-0 | Isizukulwana esitsha sokufumana ubunzima kunye nemiphetho yokusika |
IAndarine (S4) | 401900-40-0 | i-agonist inxalenye, ejoliswe ikakhulu kunyango lwe-benign prostatic hypertrophy |
MK-677 | 15972-10-0 | I-hormone yokukhula secretagogue, unyango lokutyeba, unyango oluthembisayo kunyango lobuthathaka kubantu abadala |
I-LGD-4033 | 1165910-22-4 | Iprofayili ye-pharmacological efana naleyo ye-enobosarm, i-Ostarine, i-MK-2866 |
GW1516 | 317318-70-0 | Ukutyeba ngokugqithiseleyo, isifo seswekile, i-dyslipidemia kunye nesifo senhliziyo |
MK2866 | 841205-47-8 | Umyalelo wonyango wokuthintela i-cachexia, i-atrophy, kunye ne-sarcopenia kunye neHormone okanye i-Testoserone Replacement Therapy. |
SR9009 | 1379686-30-2 | phantsi kophuhliso kwi-Scripps Research Institute (TSRI), kwandisa inqanaba lomsebenzi we-metabolic kwizihlunu zamathambo eempuku |
Apha | 2627-69-2 | isebenza ngokungena kumachibi e-nucleoside, ukwandisa kakhulu amanqanaba e-adenosine ngexesha lokuphuka kwe-ATP |
YK11 | 431579-34-9 | I-YK11: i-SARM kunye ne-myostatin inhibitor kwenye |